The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
D | Dermatologicals | |
2
|
D07 | Corticosteroids, dermatological preparations | |
3
|
D07A | Corticosteroids, plain | |
4
|
D07AD | Corticosteroids, very potent (group IV) | |
5
|
D07AD01 | Clobetasol |
| Active Ingredient |
|---|
|
Clobetasol propionate, like other topical corticosteroids, has anti-inflammatory, antipruritic, and vasoconstrictive properties. Corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. |
| Document | Type | Information Source | |
|---|---|---|---|
| CLARELUX Cutaneous foam | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| CLODERM Cream | MPI, US: SPL/Old | FDA, National Drug Code (US) | |
| DERMOVATE Scalp application | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| ETRIVEX Shampoo | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| MEDODERMONE Cream | MPI, EU: SmPC | Υπουργείο Υγείας (CY) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.